Guillain-Barre syndrome

This Phase 3 trial tested the drug eculizumab in 57 people with severe Guillain-Barré syndrome (GBS), a rare nerve disorder that can cause paralysis. Participants received either eculizumab or a placebo once a week for four weeks, alongside standard treatment. The study measured …

This trial tests whether combining proprioceptive neuromuscular facilitation (a type of stretching that improves flexibility and strength) with core strengthening exercises can help people with Guillain-Barré syndrome recover balance, muscle strength, and the ability to perform d…

This study tested whether the Atalante X exoskeleton, a robotic leg brace, is safe and helpful for people with Guillain-Barré syndrome who cannot walk. Eleven participants used the device in 20 training sessions over six weeks. Researchers measured safety, ease of use, and any im…

This study tested whether robotic training that adjusts errors based on each person's abilities can improve motor learning in healthy adults and people with neurological conditions like stroke. Over 250 participants performed arm tasks with robotic devices while researchers measu…